My Quote Request
No products added yet
6505-01-208-6253
20 Products
NDC51079-0434-20
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505012086253
NSN
6505-01-208-6253
NDC51079-0434-20
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505012086253
NSN
6505-01-208-6253
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 20 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
8010
MINERAL INJECTION,TRACE ELEMENTS
NSN, MFG P/N
6505012088523
NSN
6505-01-208-8523
8010
MINERAL INJECTION,TRACE ELEMENTS
NSN, MFG P/N
6505012088523
NSN
6505-01-208-8523
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MICROGRAMS CHROMIUM PER MILLILITER AND 1.000 MILLIGRAMS COPPER PER MILLILITER AND 0.500 MILLIGRAMS MANGANESE PER MILLILITER AND 4.000 MILLIGRAMS ZINC PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00548-8010-00
MINERAL INJECTION,TRACE ELEMENTS
NSN, MFG P/N
6505012088523
NSN
6505-01-208-8523
NDC00548-8010-00
MINERAL INJECTION,TRACE ELEMENTS
NSN, MFG P/N
6505012088523
NSN
6505-01-208-8523
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MICROGRAMS CHROMIUM PER MILLILITER AND 1.000 MILLIGRAMS COPPER PER MILLILITER AND 0.500 MILLIGRAMS MANGANESE PER MILLILITER AND 4.000 MILLIGRAMS ZINC PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00182-1576-26
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012090718
NSN
6505-01-209-0718
NDC00182-1576-26
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012090718
NSN
6505-01-209-0718
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: THE CALCIUM CARBONATE IS DERIVED FROM OYSTER SHELLS
Related Searches:
OYST-CAL TABLETS
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012090718
NSN
6505-01-209-0718
OYST-CAL TABLETS
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012090718
NSN
6505-01-209-0718
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: THE CALCIUM CARBONATE IS DERIVED FROM OYSTER SHELLS
Related Searches:
6505-01-C18-0860
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012090719
NSN
6505-01-209-0719
6505-01-C18-0860
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012090719
NSN
6505-01-209-0719
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00004-0047-01
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012090719
NSN
6505-01-209-0719
NDC00004-0047-01
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012090719
NSN
6505-01-209-0719
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TARACTAN
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012090719
NSN
6505-01-209-0719
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
INDOCIN
INDOMETHACIN SODIUM,USP
NSN, MFG P/N
6505012091192
NSN
6505-01-209-1192
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS INDOMETHACIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN SODIUM STERILE USP 1MG 3 SINGLE DOSE VIALS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 3
Related Searches:
INDOCIN INJECTION
INDOMETHACIN SODIUM,USP
NSN, MFG P/N
6505012091192
NSN
6505-01-209-1192
INDOCIN INJECTION
INDOMETHACIN SODIUM,USP
NSN, MFG P/N
6505012091192
NSN
6505-01-209-1192
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS INDOMETHACIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN SODIUM STERILE USP 1MG 3 SINGLE DOSE VIALS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 3
Related Searches:
NDC00006-3406-17
INDOMETHACIN SODIUM,USP
NSN, MFG P/N
6505012091192
NSN
6505-01-209-1192
NDC00006-3406-17
INDOMETHACIN SODIUM,USP
NSN, MFG P/N
6505012091192
NSN
6505-01-209-1192
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS INDOMETHACIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN SODIUM STERILE USP 1MG 3 SINGLE DOSE VIALS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 3
Related Searches:
NDC00173-0356-32
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012091205
NSN
6505-01-209-1205
NDC00173-0356-32
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012091205
NSN
6505-01-209-1205
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5MG BOTTLE 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE
SPECIAL FEATURES: BOTTLE WITH NOT LESS THAN 100 ML CAPACITY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ZINACEF
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012091205
NSN
6505-01-209-1205
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5MG BOTTLE 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE
SPECIAL FEATURES: BOTTLE WITH NOT LESS THAN 100 ML CAPACITY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
MS CONTIN
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012091206
NSN
6505-01-209-1206
MS CONTIN
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012091206
NSN
6505-01-209-1206
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS MORPHINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE EXTENDED-RELEASE TABLETS 30MG 50S BT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: RELEASED OVER 12 HOUR PERIOD
THERAPEUTIC EQUIVALENT: MS CONTIN BY PURDUE FREDERICK
Related Searches:
NDC00034-0515-50
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012091206
NSN
6505-01-209-1206
NDC00034-0515-50
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012091206
NSN
6505-01-209-1206
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS MORPHINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE EXTENDED-RELEASE TABLETS 30MG 50S BT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: RELEASED OVER 12 HOUR PERIOD
THERAPEUTIC EQUIVALENT: MS CONTIN BY PURDUE FREDERICK
Related Searches:
NDC00172-4365-60
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012091212
NSN
6505-01-209-1212
NDC00172-4365-60
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012091212
NSN
6505-01-209-1212
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LABETALOL HCL TABLETS 200MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-8203-89
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012091212
NSN
6505-01-209-1212
NDC00182-8203-89
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012091212
NSN
6505-01-209-1212
MFG
IVAX PHARMACEUTICALS INC . DIV DIVISION OF TEVA PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LABETALOL HCL TABLETS 200MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
019630
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
019630
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: RETROGRADE CYSTOURETHROGRAPHY
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER; SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 500 ML; NOT INTENDED FOR INTRAVASCULAR INJECTION
TOTAL PRIMARY CONTAINER QUANTITY: 8
Related Searches:
NDC50419-0196-30
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
NDC50419-0196-30
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: RETROGRADE CYSTOURETHROGRAPHY
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER; SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 500 ML; NOT INTENDED FOR INTRAVASCULAR INJECTION
TOTAL PRIMARY CONTAINER QUANTITY: 8
Related Searches:
UROVIST CYSTO
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
UROVIST CYSTO
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012091874
NSN
6505-01-209-1874
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: RETROGRADE CYSTOURETHROGRAPHY
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER; SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 500 ML; NOT INTENDED FOR INTRAVASCULAR INJECTION
TOTAL PRIMARY CONTAINER QUANTITY: 8
